On Monday I attended the first meeting of our Research and Innovation Steering Group. Chaired by the Trust Chairman, Melloney Poole the group has been established to refresh and oversee the implementation of our research and innovation strategy. We hope it will help promote faster uptake and dissemination of research and innovation within the Trust and ultimately allow our patients access to more cutting edge technology and treatments. During the meeting we had a powerful presentation from Annabelle Glanville-Hearson, a member of our patient research ambassador group who clearly articulated the benefits that a research led approach can bring to patient care. The group will meet quarterly and I look forward to reporting back on their successes.
Last week I let you know that Dr Matt Hayman is leaving the Trust at the end of March and I’m delighted to announce that following an external recruitment process, Mr Constantinos Yiangou will be taking over as Divisional Director for Networked Services. Constantinos is well known across the Trust having previously been Chief of Service for Surgery and Cancer and has also provided expert leadership as Associate Medical Director. Constantinos is currently Trust Lead Cancer Clinician and I’m pleased to say he will be continuing in this role when he moves into the Divisional Director post. I’m sure you will join me in congratulating Constantinos on his appointment to the new role.
This week we had confirmation of funding from commissioners to support a Child and Adolescent Mental Health liaison service in the hospital from 4pm-midnight seven days a week. We are working with our commissioners to get the service up and running as soon as possible, adopting the learning from a pilot project some months ago. This is extremely welcome news as it will provide support to some of our most vulnerable patients and ensure they can be best supported for both their physical and mental health needs whilst being cared for in the hospital.
More positive news this week came in the form of confirmation that we have one of the lowest rates of surgical site infection following knee replacement surgery. Public Health England undertook the review of the data for July to September last year. We carry out over 600 knee replacements a year in the Trust and this is reassuring for all patients who undergo this procedure, helping ensure they are able to leave hospital without complications, to continue their rehabilitation. This is a credit to the fantastic treatment and care provided to our patients by our Orthopaedic theatres, wards and multi-disciplinary teams.
Next week we say a fond farewell to our Chief Nurse Theresa Murphy. Theresa has made a huge impact in her time with the Trust and is well known and liked by both staff and patients alike. I think I speak for us all when I say Theresa’s leadership of nursing in Portsmouth has been exemplary. I want to thank her for her energy, passion and most of all her single minded pursuit of doing what is right for every one of our patients. Interviews for Theresa’s permanent replacement will take place on 8 March and we have a strong field of candidates. In the interim, short term cover will be provided from within the Executive team in the first instance, although we may need to add to this with external support depending on the start date of the appointee to the substantive role. I will of course, keep you updated.
I know this week has been another very busy week for many departments across the site, as we head through the final weeks of winter, but as ever, thank you for all you do for the patients we serve.